Stacey Curtiss

Stacey Curtiss has a diverse work experience spanning over two decades. Stacey'smost recent position was as the Vice President of Medical Affairs at REGENXBIO Inc., where they held the role from February 2020 onwards. Prior to that, Stacey served as the Senior Director and Head of Medical Affairs at the same company from June 2019 to February 2020.

Before joining REGENXBIO Inc., Stacey worked at Akili Interactive as the Senior Director of Medical Affairs and Medical Science Liaison Team Lead from May 2018 to June 2019.

From 2016 to 2017, Stacey worked at Ironshore Pharmaceuticals & Development, Inc. Stacey held the positions of Global Lead for Medical Science Liaisons and Acting Head of Medical Affairs during their tenure. In these roles, they managed a national team of medical science liaisons, developed MSL strategies aligned with business objectives, and oversaw various responsibilities in the medical affairs organization.

Stacey's earlier experience includes roles at Shire Pharmaceuticals, where they served as the Regional Lead for the Neuroscience MSL Team and Senior II Medical Science Liaison. Stacey significantly expanded the MSL team and led the onboarding process for the East US region. Stacey'stherapeutic areas of expertise at Shire Pharmaceuticals included CNS disorders and nephrology.

Stacey's career began at St. Mary's Health Center, where they worked as a Clinical Coordinator from 1999 to 2002. Stacey later moved on to Saint Peter's University Hospital, where they held the role of Assistant Manager and Clinical Coordinator from 2002 to 2005.

Stacey Curtiss attended the University of Iowa from 1992 to 1998, where they earned a PharmD degree in Pharmacy.